Express Pharma - Page 483 of 2244 - Express Pharma

Alembic Pharma gets USFDA nod for Ciprofloxacin and Dexamethasone Otic Suspension USP, 0.3% / 0.1%

NPPA caps trade margins at 30 per cent for 137 anti-cancer medicines

Panel Discussion: From Panjim to the World — Goa’s export playbook

Pharma counterfeiting endangers public health and economy

Lupin launches Formoterol Fumarate inhalation solution in US

US FDA gives final approval to Alembic Pharma’s Diclofenac Sodium Topical Solution

VAV Lipids showcases its lipid product range at CPHI Frankfurt

Akums enters into joint association with Leiutis and Biophore to bring first-of-its-kind therapeutics to India

Express Pharma December 2022

Compliance Made Easy: Demystifying USP and ICH Q3D guidelines for Elemental Impurities | 8th December 2022

US FDA approves JB Pharma’s generic Venlafaxine extended-release tablets

CDSCO approves AstraZeneca’s Dapagliflozin with additional indication for treating CKD and heart failure patients

Gland Pharma enters into a Put Option Agreement to acquire 100 per cent of Cenexi Group